Oncoinvent ASA

Director's Dealing • Dec 8, 2025

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Charles Gillies O'Bryan-Tear
2	Reason for the notification
a)	Position/status		Primary insider and chairperson of the board of directors.
b)	Initial notification /Amendment	Initial notification
3	auction monitor	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a)	Business name	Oncoinvent ASA
b)	LEI code	213800TYYFXKYF3V2A23
4		Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type of transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument	Shares in Oncoinvent ASA (ISIN NO0013251173)
	Identification code	ISIN: NO0013251173
b)	Nature of the transaction	Subscription and allocation of underwriting commission shares in relation to a rights issue
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0	0.50	216,000
		0 Sum	0	0
d)	Aggregated information
	- Aggregated volume	216,000 shares
	- Aggregated price	NOK 108,000.00
e)	Date of the transaction	2025-12-05
f)	Place of transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Teakay Invest AS
2	Reason for the notification
a)	Position/status	Close associate to primary insider and member of the board of directors, Ingrid Teigland Akay.
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor
a)	Business name	Oncoinvent ASA
b)	LEI code	213800TYYFXKYF3V2A23
4		Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type of transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument	Shares in Oncoinvent ASA (ISIN NO0013251173)
	Identification code	ISIN: NO0013251173
b)	Nature of the transaction	Subscription and allocation of underwriting commission shares in relation to a rights issue
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0	0.50	105,316
		0 Sum	0	0
d)	Aggregated information
	- Aggregated volume	105,316 shares
	- Aggregated price	NOK 52,658.00
e)	Date of the transaction	2025-12-05
f)	Place of transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Abakus Invest AS
2	Reason for the notification
a)	Position/status		Close associate to primary insider and Chief Executive Officer, Øystein Soug.
b)	Initial notification /Amendment	Initial notification
3	auction monitor	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a)	Business name	Oncoinvent ASA
b)	LEI code	213800TYYFXKYF3V2A23
4		Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type of transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument	Shares in Oncoinvent ASA (ISIN NO0013251173)
	Identification code	ISIN: NO0013251173
b)	Nature of the transaction	Subscription and allocation of underwriting commission shares in relation to a rights issue
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0	0.50	120,000
		Sum 0	0	0
d)	Aggregated information
	- Aggregated volume	120,000 shares
	- Aggregated price	NOK 60,000.00
e)	Date of the transaction	2025-12-05
f)	Place of transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	HVentures Capital I AB
2	Reason for the notification
a)	Position/status	Close associate to primary insider and member of the board of directors, Ingrid Teigland Akay.
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor
a)	Business name	Oncoinvent ASA
b)	LEI code		213800TYYFXKYF3V2A23
4		Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type of transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument	Shares in Oncoinvent ASA (ISIN NO0013251173)
	Identification code	ISIN: NO0013251173
b)	Nature of the transaction	Subscription and allocation of underwriting commission shares in relation to a rights issue
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0	0.50	1,278,616
		Sum 0	0	0
d)	Aggregated information
	- Aggregated volume	1,278,616 shares
	- Aggregated price	NOK 639,308.00
e)	Date of the transaction	2025-12-05
f)	Place of transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Hadean Capital I AS
2	Reason for the notification
a)	Position/status	Close associate to primary insider and member of the board of directors, Ingrid Teigland Akay.
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor
a)	Business name	Oncoinvent ASA
b)	LEI code	213800TYYFXKYF3V2A23
4		Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type of transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument	Shares in Oncoinvent ASA (ISIN NO0013251173)
	Identification code	ISIN: NO0013251173
b)	Nature of the transaction	Subscription and allocation of underwriting commission shares in relation to a rights issue
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0	0.50	2,818,972
		Sum 0	0	0
d)	Aggregated information
	- Aggregated volume	2,818,972 shares
	- Aggregated price	NOK 1,409,486.00
e)	Date of the transaction	2025-12-05
f)	Place of transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Hadean Growth Fund I AS
2	Reason for the notification
a)	Position/status	Close associate to primary insider and member of the board of directors, Ingrid Teigland Akay.
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the auction monitor
a)	Business name	Oncoinvent ASA
b)	LEI code	213800TYYFXKYF3V2A23
4		Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type of transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument	Shares in Oncoinvent ASA (ISIN NO0013251173)
	Identification code	ISIN: NO0013251173
b)	Nature of the transaction	Subscription and allocation of underwriting commission shares in relation to a rights issue
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0	0.50	1,373,520
		Sum 0	0	0
d)	Aggregated information
	- Aggregated volume	1,373,520 shares
	- Aggregated price	NOK 686,760.00
e)	Date of the transaction	2025-12-05
f)	Place of transaction	XOFF – Outside a trading venue

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Itza AS
2	Reason for the notification
a)	Position/status		Close associate to primary insider and Chief Financial Officer, Tore Kvam.
b)	Initial notification /Amendment	Initial notification
3	auction monitor	Details of the issuer, an emission allowances market participant, auction platform, the auctioneer, or the
a)	Business name	Oncoinvent ASA
b)	LEI code	213800TYYFXKYF3V2A23
4		Details of the transaction(s): Section to be repeated for i) each type of instrument ii) each type of transaction, iii) each date, and iv) each place where the transaction(s) have been conducted
a)	Description of the financial instrument/type of instrument	Shares in Oncoinvent ASA (ISIN NO0013251173)
	Identification code	ISIN: NO0013251173
b)	Nature of the transaction	Subscription and allocation of underwriting commission shares in relation to a rights issue
c)	Price(s) and volume(s)	Currency	Price(s)	Volume(s)
		NOK 0	0.50	72,000
		Sum 0	0	0
d)	Aggregated information
	- Aggregated volume	72,000 shares
	- Aggregated price	NOK 36,000.00
e)	Date of the transaction	2025-12-05
f)	Place of transaction	XOFF – Outside a trading venue